Effectiveness of a Subcutaneously Administered Long-acting Insulin Added to Insulin Drip Therapy as Compared With Standard Insulin Drip Treatment.

Trial Profile

Effectiveness of a Subcutaneously Administered Long-acting Insulin Added to Insulin Drip Therapy as Compared With Standard Insulin Drip Treatment.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Oct 2012

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin; Insulin detemir
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2012 Primary endpoint 'Glucose-level' has been met.
    • 08 Jun 2012 Status changed from recruiting to completed.
    • 08 Jun 2012 Results published in the Journal of Clinical Endocrinology and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top